Business Wire

Invacare Take Powerchairs to a New Level

Del

Global brand leader Invacare is once again raising the bar in the powerchair market, following on from the successful launch of the LiNX control system last year. Invacare has taken the smart technology a step further with a new touch screen remote, in-built Bluetooth technology, enhanced programming features and a range of specialist controls, all available on the remarkable Invacare LiNX powerchair range.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170831005621/en/

Invacare TDX SP2 with LiNX (Photo: Business Wire)

Invacare TDX SP2 with LiNX (Photo: Business Wire)

Touch screen remote

Following extensive trials and consumer-led insights, Invacare can now bring touch screen technology, which is used daily on devices such as smartphones and tablets, to powerchairs. The innovative REM400 remote has an impressive 3.5” colour touch screen that puts the user in complete control. Its features include:

  • Swipe or tap operation
  • Direct or menu navigation access to profiles and functions
  • Adjustable brightness
  • Glove mode setting
  • Screen lock out function
  • Configured for left or right handed use

And it doesn’t end there. The REM400 has built-in Bluetooth which allows connection to PC’s, laptops and Macs. Its integrated mouse mover with on screen mouse clicks lets users connect to their world through their remote.

One of the great benefits of a touch screen remote is that there are no fixed buttons. This makes the REM400 suitable for those with more complex physical and cognitive needs.

Enhanced programming features

LiNX allows professionals to diagnose and update powerchairs more intuitively through its clean and simple interface. Changes can be made to a powerchair via a laptop, PC or iOS device which are connected to the powerchair through a wireless LiNX Access Key.

What makes LiNX programming so innovative is its ‘live’ feature. Changes can be made to the forward, reverse and turn speeds whilst the powerchair is being driven by the user. This increases the driving efficiency and experience and makes set-ups and adjustments easier and quicker for professionals. Feedback is immediate and it ensures the powerchair is configured specifically to the user.

The LiNX system also allows professionals to mix and match the drive, seating and environmental controls in-order-to customise the display to suit the user’s lifestyle. E.g. The profiles can be customised by names such as Home, Outdoor and Work, with functions specific to each one. Profiles can also be set by user input options i.e. head control.

Specialist controls

To maximise a user’s control and independence, the REM400 allows a selection of specialist user inputs to be used on Invacare’s remarkable powerchairs. They range from head controls, chin controls, Sip ‘n’ puff systems, joystick options, proximity switches and dual controls, allowing Invacare to provide a control solution for many powerchair users. To help professionals select the best control for a powerchair user,

Invacare has put together a useful app with five simple steps to assist with the process. Take a look at the app by visiting www.linx4you.com, plus it can be downloaded from the Google Play Store and Apple App Store.

The above offering is available on all Invacare LiNX powerchairs, with a selection of the specialist controls only compatible with the TDX SP2 Ultra Low Maxx - and it is with this chair that Invacare is now able to fully enter the complex rehab market.

TDX SP2 base update

The renowned base with its minimalist black bodywork has been further enhanced with an optional single sided fork. With no protruding screws or fork parts, it not only makes the chair look more appealing but also minimises the front width of the base.

What further complements the TDX SP2 is its new black non-marking tyres and castors along with its black rim, giving this already exceptional chair a more sophisticated appearance.

And finally, the TDX SP2 wouldn’t be a perfect fit for a user’s lifestyle if it didn’t come with a range of individual colour finishes. Shrouds come in a choice of ten colours that are both neutral and vibrant, with 10 attractive rim inserts also available. That’s 100 colour combinations in total!

Announcing the LiNX enhancement, Ilona Wiemann, Global Product Development Manager for Powered Mobility at Invacare International said: “Invacare is once again revolutionising power mobility and setting a new benchmark in this market segment. When first launched last year, LiNX promised to be the start of something different and special and it didn’t disappoint and now we are back with even more innovations and smart technology.”

To find out more about Invacare LiNX, please visit www.invacarelinx.com.

To find out more about the TDX SP2 with Ultra Low Maxx and LiNX, please visit www.invacareULM.com.

About Invacare

Invacare Corporation (NYSE:IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The Company currently has 5,400 associates and markets its products in approximately 80 countries around the world.

Contact information

Invacare
Samantha Hatchett
EMEA Marketing Communications Executive
01656 776236
or
EMEA Communication Team
Invacare International Sàrl
emeacomms@invacare.com
www.invacare.eu.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20Pressemelding

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31Pressemelding

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

Double Win for Vocalink at the 2017 Payments Awards17.11.2017 09:35Pressemelding

Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim

Envion AG: Start-up from the Heart of Berlin Has Pioneered Decentralized Mobile Mining by Combining Blockchain with Regenerative Energy17.11.2017 09:00Pressemelding

Envion AG has created a technology for the first truly mobile data-center that uses low-priced local energy to mine a broad spectrum of cryptocurrencies (Bitcoin, Ethereum, etc.). By harvesting locally available clean energy right at the source, envion can operate at lower costs than competitors and at the same time reduces the CO2 footprint of the blockchain industry. Envion aims at decentralizing the highly-concentrated mining market (China holds 80% in Bitcoin mining) and at bringing control of the market back to the users. That’s why envion gives 100% of its mining profits back to its community. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171117005011/en/ Envion - World's Most Profitable Standard of Self-Expanding Crypto Infrastructure (Photo: Business Wire) Current challenges in the energy

Chugai's HEMLIBRA® Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors16.11.2017 23:30Pressemelding

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the U.S. Food and Drug Administration (FDA) has approved the bispecific antibody emicizumab (US product name: HEMLIBRA®) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. This represents the first regulatory approval for HEMLIBRA® around the world. The US Biologics License Application (BLA) was submitted by Genentech, a member of Roche Group. “We are pleased that HEMLIBRA, a biopharmaceutical created by Chugai scientists based on their exceptional idea, has received its first regulatory approval,” said Chugai’s President & COO, Tatsuro Kosaka. “HEMLIBRA is a first in class biopharmaceutical which is an advancement on the current limited treatment options available for pat

Pacific Drilling Receives Approval of First Day Motions16.11.2017 22:08Pressemelding

Pacific Drilling S.A. (OTCPink: PACDQ) (“Pacific Drilling” or the “Company”) today announced that the United States Bankruptcy Court for the Southern District of New York has granted the relief requested by the Company in certain first day motions related to ordinary course business activities, subject to certain modifications at the request of the Court, the United States Trustee and stakeholders. The approved motions give us the authority to, among other things, continue to pay employee wages and benefits without interruption, to utilize our current cash management system, and to pay certain foreign and critical vendors for goods and services provided prior to the petition date. All vendors will be paid in full and in cash on normal payment terms for all goods and services provided on or after the petition date. Paul Reese, Chief Executive Officer of Pacific Drilling, said, “With the

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom